DLA Piper provides comprehensive EU and Belgian regulatory, litigation, contractual and transactional support. The team is particularly well known for its work in complex technology mandates such as gene therapies, radiopharmaceuticals and medical devices. Co-head Marco de Morpurgo focuses on government regulation in the life sciences industry, leading alongside Joost Hans, who is recognised for his expertise in competition law. Jean-Christophe Top assists with the commercialisation of advanced therapies and compliance frameworks under EU and Benelux law.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘DLA Piper offers a great range of competencies in-house. The team is skilled and reactive and is adapting to the client's needs. It understands the technicalities as well as the political dynamics of our organisation.’
- ‘Deep specialised knowledge and competences within the pharmaceutical sector. Key contributors are Jean-Christophe Top and Joost Haans.’
- ‘Jean-Christophe Top has been a key contributor to the establishment of our contractual framework. In this context, Jean-Christophe demonstrates a profound understanding of regulatory matters, combined with outstanding drafting skills and attention to detail.'
Key clients
- AbbVie Acadia Pharmaceuticals Amicus Therapeutics argenx AstraZeneca AZ Delta Bristol Myers Squib CoreAalst Danone Dentsply Sirona European Medicines Verification Organisation (EMVO) Gilead GlaxoSmithKline Guerbet Incyte Iovance Biotherapeutics Ipsen IVC Evidensia Kartos Therapeutics Madrigal Pharmaceuticals Medtronic NeuroTrauma Sciences NewLeaf Nexuzhealth Nipro Novartis Ontex Owkin Pfizer Pierre Fabre ResMed Sanofi Sarepta Therapeutics Stryker Syneos Health Takeda UCB Unilabs
Work highlights
Advising the European Medicines Verification Organisation (EMVO) on regulatory compliance, data protection, corporate and policy matters related to the Falsified Medicines Directive. Its work helps maintain the integrity and evolution of the European Medicines Verification System, ensuring alignment with evolving standards such as GAMP5® and supporting EMVO’s strategic operations across the EU.
Advising Acadia Pharmaceuticals on the European launch of trofinetide, guiding strategy across reimbursement, promotion, pharmacovigilance, quality management, supply chain design and commercial partnerships. Work spans multiple jurisdictions, addressing regulatory grey areas and divergent national rules, and developing tailored, compliant solutions for a smooth and effective EU market entry.
Advising Nipro on a wide range of regulatory and legal matters across its medical device and chemical product portfolio, including revising its quality management system, assessing borderline product classifications, handling commercial contracts, and engaging with authorities and notified bodies. It also supports the implementation of CAPAs to ensure compliance with evolving regulatory standards.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Marco de Morpurgo; Joost Haans
Other key lawyers
Jean-Christophe Top